ARS Pharmaceuticals’ anaphylaxis nasal spray gains FDA approval
The US FDA has approved ARS Pharmaceuticals' neffy, an anyphylaxis nasal spray 2mg, for the emergency treatment of allergic reactions.
The US FDA has approved ARS Pharmaceuticals' neffy, an anyphylaxis nasal spray 2mg, for the emergency treatment of allergic reactions.
What's Your Reaction?
